Citadel Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-51,397
Closed -$3.5M 7286
2022
Q3
$3.5M Sell
51,397
-1,300,157
-96% -$88.5M ﹤0.01% 2192
2022
Q2
$43.2M Sell
1,351,554
-614,378
-31% -$19.6M 0.01% 435
2022
Q1
$68.1M Buy
1,965,932
+280,076
+17% +$9.7M 0.01% 309
2021
Q4
$49.3M Buy
1,685,856
+1,650,927
+4,727% +$48.3M 0.01% 489
2021
Q3
$890K Buy
+34,929
New +$890K ﹤0.01% 3907
2021
Q2
Sell
-1,097,553
Closed -$44.7M 7400
2021
Q1
$44.7M Buy
1,097,553
+720,308
+191% +$29.4M 0.01% 518
2020
Q4
$16.3M Sell
377,245
-298,927
-44% -$12.9M ﹤0.01% 967
2020
Q3
$37.3M Buy
676,172
+385,407
+133% +$21.3M 0.01% 496
2020
Q2
$18.4M Buy
290,765
+102,171
+54% +$6.45M 0.01% 782
2020
Q1
$9.64M Buy
188,594
+1,244
+0.7% +$63.6K ﹤0.01% 1022
2019
Q4
$14.9M Buy
187,350
+174,441
+1,351% +$13.9M 0.01% 954
2019
Q3
$626K Sell
12,909
-214,698
-94% -$10.4M ﹤0.01% 3303
2019
Q2
$12M Buy
227,607
+29,402
+15% +$1.55M 0.01% 1080
2019
Q1
$10.5M Buy
198,205
+166,583
+527% +$8.82M 0.01% 1089
2018
Q4
$1.3M Sell
31,622
-38,729
-55% -$1.59M ﹤0.01% 2578
2018
Q3
$2.67M Buy
70,351
+39,619
+129% +$1.51M ﹤0.01% 1992
2018
Q2
$1.39M Sell
30,732
-19,178
-38% -$867K ﹤0.01% 2408
2018
Q1
$2.41M Sell
49,910
-666,701
-93% -$32.2M ﹤0.01% 1807
2017
Q4
$28.2M Buy
716,611
+449,828
+169% +$17.7M 0.02% 559
2017
Q3
$8.28M Sell
266,783
-1,178,352
-82% -$36.6M 0.01% 1019
2017
Q2
$39.5M Buy
1,445,135
+607,883
+73% +$16.6M 0.03% 371
2017
Q1
$30.9M Buy
837,252
+807,316
+2,697% +$29.7M 0.03% 431
2016
Q4
$433K Buy
29,936
+1,809
+6% +$26.2K ﹤0.01% 2577
2016
Q3
$648K Buy
+28,127
New +$648K ﹤0.01% 2256
2016
Q2
Hold
0
4061